The Centre de recherche Saint-Louis

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Psoriasis2 trials

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials

Running trials

• Active, not recruiting

  A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis

  NCT06934226· Phase 3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

  NCT06039189· Phase 3· Janssen Research & Development, LLC· Source